Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Gastrointestinal Dysmotility: full-pipeline trial registry
A small indexed set (3 trials) with no open enrollment listed right now.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · none currently recruiting · #5,209 of 28,707 conditions by registered trial count
Gastrointestinal Dysmotility: 3 US clinical trials tracked, none currently recruiting.
Gastrointestinal Dysmotility is the subject of 3 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Tranzyme, running 1 of these trials.
Enrollment posture brief
Registry condition gastrointestinal-dysmotility
OPEN 0 | RECR 0% | LATE 1 | EARLY 1 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Gastrointestinal Dysmotility has no open enrollment in this registry pull (3 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Gastrointestinal Dysmotility on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Gastrointestinal Dysmotility is recruiting below its size-band peers.
0 of 3 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Indexed trials (enrollment closed)
3 total, page 1 of 1
Ulimorelin Study of Efficacy and Safety (ULISES 007)
Tranzyme
NCT01285570
Safety and Efficacy of Ipamorelin Compared to Placebo for the Recovery of Gastrointestinal Function
Helsinn Therapeutics (U.S.)
NCT01280344
Enteric Neural Precursor Cells (ENPC) in the Human Gut
Johns Hopkins University
NCT04880538
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Gastrointestinal Dysmotility records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Gastrointestinal Dysmotility trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Gastrointestinal Dysmotility page
3 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Gastrointestinal Dysmotility trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Tranzyme sponsors the most Gastrointestinal Dysmotility trials on record, review their full trial history before evaluating a specific study. See Tranzyme's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Gastrointestinal Dysmotility condition card totals 3 registered trials; most-linked intervention 5% dextrose in water; top US site state Illinois. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.